Publication Name	World Journal of Cardiology
Manuscript ID	109731
Country	United States

Category	Medicine, General & Internal
Manuscript Type	Meta-Analysis
Article Title	Sodium-glucose cotransporter 2 inhibitor in heart failure patients and their outcomes: A meta-analysis of randomized controlled trials
Manuscript Source	Invited Manuscript
All Author List	Saketh Parsi, Pallavi D Shirsat, Lakshmi P Mahali, Salim Surani and Rahul Kashyap
Funding Agency and Grant Number
Corresponding Author	Salim Surani, Professor, Department of Medicine and Pharmacology, Texas AM University, 40 Bizzell Street, College Station, TX 77843, United States. srsurani@hotmail.com
Key Words	Sodium-glucose cotransporter 2 inhibitor; Heart failure; Hospitalizations for heart Failure; Cardiovascular deaths; All-cause mortality
Core Tip	Sodium-glucose cotransporter 2 (SGLT2) inhibitor have been incorporated into heart failure (HF) treatment guidelines due to their established benefits in patients with HF. They can be initiated in HF patients irrespective of their diabetes history. These medications significantly lower the risk of hospitalization for HF. SGLT2 inhibitor may also reduce cardiovascular deaths and all-cause mortality in HF patients, though the statistical significance of these outcomes has not been consistently demonstrated across all studies.
Citation	Parsi S, Shirsat PD, Mahali LP, Surani S, Rahul Kashyap. Sodium-glucose cotransporter 2 inhibitor in heart failure patients and their outcomes: A meta-analysis of randomized controlled trials. World J Cardiol 2025; In press

Received	2025-05-20 06:50
Peer-Review Started	2025-05-20 06:50
To Make the First Decision
Return for Revision	2025-05-24 02:46
Revised	2025-06-05 01:31
Second Decision	2025-09-04 02:51
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-09-04 06:32
Articles in Press	2025-09-04 06:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com